Next Article in Journal
Influence of Blueberry Mosaic Disease on Polyphenolic Profile and Antioxidant Capacity of Highbush Blueberry ‘Duke’ Fruits
Previous Article in Journal
Selenium: A Key Element in Inflammatory Bowel Disease
Previous Article in Special Issue
Impact of a Formulation Containing Chaga Extract, Coenzyme Q10, and Alpha-Lipoic Acid on Mitochondrial Dysfunction and Oxidative Stress: NMR Metabolomic Insights into Cellular Energy
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 14
Issue 11
10.3390/antiox14111300
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Resveratrol Alleviates Effects of LPS on Estrogen Synthesis, Oxidative Stress, Inflammation, and Pyroptosis of Goat Granulosa Cells by Activating the PPARG/NRF2/HO-1 Signaling Pathway

by
Jie Zhao
,
Xianyi Zhou
,
Zhen Cang
,
Xin Liu
,
Muhammad Tariq
and
Dagan Mao
*
College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China
*
Author to whom correspondence should be addressed.
Antioxidants 2025, 14(11), 1300; https://doi.org/10.3390/antiox14111300
Submission received: 23 September 2025 / Revised: 15 October 2025 / Accepted: 20 October 2025 / Published: 29 October 2025
(This article belongs to the Special Issue Antioxidant Effects of Natural Compounds on Cell Metabolism)
Browse Figures
Versions Notes

Abstract

This study aims to investigate the effect and mechanism of resveratrol (RES) on lipopolysaccharide (LPS)-induced injury in goat granulosa cells (GCs). First, the appropriate time and concentration were screened for LPS (4 μg/mL, 12 h), RES (1 μM, 6 h), and GW9662 (an antagonist of PPARG, 1 μM, 12 h) through CCK8 and RT-qPCR. Then, cells were treated with LPS, RES, or/and GW9662, to examine steroidogenesis, inflammation, oxidative stress, and pyroptosis by RIA, RT-qPCR, WB, flow cytometry, and IF, respectively. Results showed that RES inhibited LPS-induced increases in MDA content, ROS production, gene expressions of IL-1β, NLRP3, Caspase1, and GSDMD, as well as protein levels of IL-1β, and GSDMD, accompanied by decreases in SOD activity, T-AOC and E2 content, gene expressions of SOD, CYP19A1, and HSD3B, and protein levels of SOD and HSD3B. Furthermore, RES inhibited LPS-induced decreases in PPARG, NRF2, and HO-1 gene expressions and protein levels. However, GW9662 could block all the alleviating effects of RES on LPS. In conclusion, RES regulates the effects of LPS on hormone secretion, inflammation, oxidative stress, and pyroptosis by modulating the PPARG/NRF2/HO-1 pathway, providing a new theoretical basis for improving goat reproduction.

1. Introduction

Oxidative stress and inflammation are the major factors that influence the functioning of the ovaries, the growth of follicles, and the quality of oocytes. Overproduction of reactive oxygen species (ROS) disrupts granulosa cell activity and steroidogenesis, resulting in reduced fertility in animals [1,2], also activates the TLR4/NF-κB signaling pathway and increases the levels of pro-inflammatory cytokines such as IL-1, IL-6, and TNF-α. The bacteria endotoxin lipopolysaccharide (LPS) stimulates oxidative stress and apoptosis in ovarian cells [3]. The effects of these inflammations disrupt hormone production and follicular development, and protective measures must be implemented to ensure that ovaries stay healthy.
Oxidative stress and inflammation have also been cited as major contributors to ovarian dysfunction and infertility in humans [4]. The uncontrolled production of reactive oxygen species (ROS) and inflammatory cytokines interferes with steroidogenesis, oocyte maturation, and follicular development, which relate to such reproductive disorders as polycystic ovary syndrome (PCOS), endometriosis, and premature ovarian failure [5]. Oxidative stress is a crucial factor affecting female reproduction in humans, as it impairs oocyte quality and disrupts embryo development. Oxidative imbalance was a determinant pathophysiology in human ovaries [6]. Inflammatory damage to granulosa cells due to (LPS) is mediated by the amplification of the TLR4/NF-KB pathway and the reduction in estrogen [7]. Therefore, the ovarian dynamics and future approaches involving antioxidation and anti-inflammatory effects may be comprehended by a more insightful evaluation of the antioxidant and anti-inflammatory effects on humans.
LPS affects the expression of the antioxidant enzyme (superoxide dismutase, SOD) and alters the cellular functional and metabolic status [8,9]. LPS causes cells to produce large amounts of inflammatory factors, such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) [10], resulting in inflammation and oxidative stress. LPS can also trigger the expressions of cysteine–aspartic acid protease 1 (Caspase1), nucleotide-binding oligomerization of domain-like receptor protein 3 (NLRP3), and gasdermin D (GSDMD) [11], which leads to pyroptosis, thus affecting the normal functions of the organism.
Resveratrol (RES) is a natural polyphenol that is widely found in grapes, red wine, and peanuts [12], with various functions, such as antioxidants, anti-inflammatory, anti-aging, and anti-obesity [13]. RES can scavenge or inhibit the generation of free radicals, thus protecting cells from oxidative damage [14], suppressing inflammatory responses, and alleviating tissue damage. It can also enhance immune activity by strengthening the immune system and restoring the impaired immune function [15]. Peroxisome proliferator-activated receptor (PPAR) is a ligand-activated nuclear receptor family that includes three subtypes: A, D, and G. Among them, PPARG is expressed in a variety of tissues, such as the brain [16], ovaries [17], liver [18] and lung [19], playing important roles in cell proliferation [20], apoptosis [21], and inflammation [22].
Despite the growing evidence of resveratrol’s antioxidant effects, its precise regulatory mechanisms in ruminant ovarian cells, particularly in goats, remain poorly defined. Studies have shown that RES can act as a ligand activator of PPARG to exert its transcriptional regulatory function [23], and RES and PPARG have a synergistic effect in the regulation of the inflammatory signaling pathway [24,25], which leads to the inhibition of pro-inflammatory cytokines and oxidative damage in various cells [23,24]. In addition, RES activates the nuclear factor erythroid 2-related factor 2 (NRF2)/heme oxygenase-1 (HO-1) signaling pathway that protects the cell against oxidative stress and inflammation [26]. RES reduced the expression of inflammatory mediators in the microglial murine cell line BV-2 [27], enhanced brain defenses against acute LPS stimuli in aged animals [28], and prevented palmitate-induced IL-6 and TNF-α in C2C12 cells [29]. RES can also reverse the fluoride-induced decrease in PPARG in the rat ameloblast cell line LS8 [30] and attenuate pyroptotic-driven damage in the rat retina and MGC by inhibiting the NLRP3/GSDMD/Caspase-1 pathway [30]. Furthermore, rosiglitazone, an agonist of PPARG, upregulated NRF2 in a concentration-dependent manner, leading to the activation of the downstream HO-1, which plays an important role in reducing inflammation [31].
Numerous studies have shown that subacute ruminal acidosis increased serum LPS level in ruminants [32,33]. Other factors like the hygiene of forage and drinking water, or diseases, could also produce large amounts of LPS in goats, which may induce ovarian inflammation, affecting both follicle development function and luteal function. Our previous studies have shown that feeding with a high-concentrate diet leads to an increase in the serum LPS of lambs, LPS affects the proliferation and hormone secretion in luteinized granulosa cells (GCs) [34], and PPARG affects the proliferation, apoptosis, and estrogen secretion in goat GCs [35].
Therefore, the purpose of the study was to examine the protective role and mechanisms of resveratrol (RES) against lipopolysaccharide (LPS)-induced oxidative stress, inflammation, pyroptosis, and disrupting the production of estrogens in goat granulosa cells (GCs). We hypothesized that RES alleviates the effect of LPS on estrogen synthesis, oxidative stress, inflammation, and pyroptosis of GCs by activating the PPARG/NRF2/HO-1 signaling pathway. In the current study, the proper concentration and time for LPS, RES, or GW9662 (an antagonist of PPARG) treatment in goat GCs were screened first by cell-counting kit-8 (CCK8) and a real-time quantitative polymerase chain reaction (RT-qPCR) to establish an inflammatory model. Then, GCs were pretreated with or without RES or/and GW9662, followed by LPS exposure, to investigate oxidative stress, inflammation, pyroptosis, E2 synthesis, and the PPARG/NRF2/HO-1 pathway by radioimmunoassay (RIA), flow cytometry, immunofluorescence (IF), RT-qPCR, and Western blot (WB), respectively, which will uncover the underlying possible mechanisms in which RES alleviates the effect of LPS in goat GCs, and provide a new strategy and insight for the treatment of reproductive disorders.

2. Materials and Methods

2.1. Cell Isolation and Culture

Goat ovaries were obtained at a slaughterhouse (Danyang, Jiangsu), placed in saline (30–35 °C, including 100 IU/mL penicillin and 100 mg/mL streptomycin), and brought back to the laboratory within 2 h for GCs isolation, as described previously [35]. Briefly, GCs from healthy follicles (2–5 mm) were washed with Phosphate-Buffered Saline (PBS) 3 times, then transferred to T-75 culture flasks with cell medium (DMEM-F12 supplemented with 10% fetal bovine serum, 100 IU/mL of penicillin, and 100 μg/mL of streptomycin). Cells were cultured in a 37 °C humidified cell incubator with 5% CO2.

2.2. Experimental Design

In the pre-experiment, cells were treated with LPS (0–16 μg/mL for 12 h), RES (0–10 μM for 12 h and 1 μM for 0–24 h), or GW9662 (0–20 μM for 12 h and 1 μM for 0–24 h) to detect GCs viability by CCK8 assay. The preliminary data and the literature on granulosa cells in goats and other animals were used to choose the initial range of LPS concentrations (0–16 μg/mL) and treatment times (0–24 h) [36,37]. The oxidative status and ROS content of GCs exposed to LPS were also detected by commercial kits and flow cytometry, respectively. Then, GCs were exposed to the selected concentrations and treatment durations of LPS, RES, and GW9662 to confirm the optimal experimental conditions by evaluating cell viability and the expression of genes related to inflammation and pyroptosis. The optimal condition was determined as 4 μg/mL at 12 h of inducing a reproducible inflammatory response in goat GCs. The 6 h RES pretreatment period was selected because it allowed sufficient activation of antioxidant signaling pathways before LPS stimulation, consistent with the results of the pre-experiment and previous studies.
Lipopolysaccharide (LPS, from Escherichia coli 055: B5, ≥99% purity; Sigma-Aldrich, L2880, St. Louis, MO, USA) was dissolved in sterile Phosphate-Buffered Saline (PBS) to prepare stock solutions. Resveratrol (RES, ≥98% purity; Selleck Chemicals, S1396, Houston, TX, USA) and GW9662 (≥98% purity; Selleck Chemicals, S2915, Houston, TX, USA), a selective PPARG antagonist, were dissolved in dimethyl sulfoxide (DMSO) to prepare 10 mM stock solutions. These were diluted with culture medium to the shown working concentrations (LPS 4 μg/mL, RES 1 μM, GW9662 1 μM). The final DMSO concentration in all treatments was <0.1%, which did not affect cell viability.
To explore whether RES alleviates the effects of LPS through PPARG, cells were divided into four groups: control (CON), LPS (4 μg/mL for 12 h), RES + LPS, and GW9662 + RES + LPS groups. Culture media and cells were collected for subsequent analyses of oxidative indexes, E2 levels, gene and protein expression, and ROS content, as described below.

2.3. Cell Viability

Cell viability was analyzed using CCK8 assay (NCM Biotech, Suzhou, Nanjing, China) according to the manufacturer’s instructions [35]. Cells were treated with specific drugs in a 96-well plate, and six replicate wells were set. After treatment, the cells were incubated with CCK-8 working solution for 2 h at 37 °C in a humidified incubator containing 5% CO2, and the absorbance was then measured at 450 nm (Thermo Fisher Scientific, Waltham, MA, USA).

2.4. Radioimmunoassay

A commercial RIA kit (Beijing North Institute of Biological Technology, Beijing, China) was used to detect E2 levels in 6-well plate media at Shanghai Xinfan Biotechnology Co., Ltd., Shanghai, China. The assay had a sensitivity of 0.02 ng/mL. The intra- and inter-assay coefficients of variation (CV) were <10% and <15%, respectively. E2 concentrations were calculated from a standard curve and reported as (ng/mL).

2.5. Measurement of the Oxidative Indexes

GCs were seeded in a 6-well plate (5 × 105 cells/well) and treated as mentioned above. The total antioxidant capacity (T-AOC, G0115W) level, superoxide dismutase (SOD, G0101W) activity, and malondialdehyde (MDA, G0109W) content in the media were analyzed using commercial kits (Suzhou Geruisi Biotechnology, Suzhou, China), according to the manufacturer’s instructions. All biochemical parameters, including enzyme activities and hormone concentrations, were expressed in (U/mL) or (ng/mL), following the manufacturer’s instructions for each commercial assay kit.

2.6. Detection of ROS

2.6.1. Flow Cytometry Analysis

GCs were seeded into 6 well-plates and treated as mentioned above. Cells were then washed 3 times by PBS for 5 min each time and centrifuged at 1000 rpm for 5 min to adjust the density to 106/mL. The intracellular ROS content was measured using a commercial kit (KGT010-1, Jiangsu KGI Biotechnology Co., Ltd., Nanjing, China). Briefly, cells were washed 3 times in serum-free medium, and then incubated with diluted DCFH-DA (10 µM) at 37 °C for 30 min, followed by washing to remove redundant DCFH-DA. The fluorescein isothiocyanate detection was performed by a BD FACSVerse™273 flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA), with an excitation wavelength of 488 nm and an emission wavelength of 530 nm. The quantification was performed using ImageJ software (version 1.53, National Institutes of Health, Bethesda, MD, USA).

2.6.2. Fluorescent Staining

GCs were seeded onto cover slips and cultured in a 6-well plate, as mentioned above. After treatment for a specific time, an appropriate volume of diluted DCFH-DA (10 µM) was added. Cells were incubated in the dark at 37 °C for 30 min. Cells were then washed with serum-free culture medium to remove redundant DCFH-DA. Images were captured using a fluorescence microscope (Nikon, Tokyo, Japan). The quantification was performed using ImageJ software (version 1.53, National Institutes of Health, Bethesda, MD, USA).

2.7. Real-Time Quantitative PCR Analysis

RT-qPCR was performed as previously described [38]. GCs were seeded in a 6-well plate and treated as mentioned above. Total RNA was isolated using RNA isolated extraction reagent (R401-01, Vazyme Biotech Co., Ltd., Nanjing, China), and reverse-transcribed to cDNA using the HiScript III RT SuperMix for qPCR (R323-01, Vazyme Biotech Co., Ltd., Nanjing, China), according to the manufacturer’s protocol. Each 20 μL of the PCR reaction was prepared as follows: 1 μL cDNA, 10 μL SYBR master mix, 8.2 μL nuclease-free water, and 0.4 μL each of forward and reverse primer pairs (10 μmol). PCR was conducted on an ABI 7300 Fast Real-time PCR System (Applied Biosystems, Foster City, CA, USA) using ChamQ Universal SYBR qPCR Master Mix (Q711, Vazyme Biotech Co., Ltd., Nanjing, China). The qPCR running system included a hold period at 95 °C for 5 min, followed by 40 cycles of 95 °C for 10 s, 60 °C for 30 s, 95 °C for 15 s, 60 °C for 1 min, and 95 °C for 15 s. RT-qPCR results were normalized to the reference gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The relative expression levels of target genes were calculated based on the threshold cycle (Ct) values, using the comparative 2−ΔΔCt formula. Each sample represented one biological replicate derived from granulosa cells that were isolated from three different goats, and each treatment was analyzed in triplicate wells. The sequences of the target gene were shown in Table 1.

2.8. Western Blot Analysis

WB was performed as previously described [39]. GCs were seeded in a 6-well plate and treated as mentioned above. Total protein was extracted with radioimmunoprecipitation assay lysate (Biosharp Life Sciences, Hefei, China), including phenylmethanesulfonylfluoride (Biosharp Life Sciences, Hefei, China). The protein concentration was detected by a bicinchoninic acid assay kit (Beyotime, Shanghai, China). Protein was separated by 10% SDS–polyacrylamide gels and transferred to polyvinylidene fluoride membranes (Millipore; Billerica, MA, USA) at 4 °C. Membranes were blocked with 5% nonfat milk for 1.5 h at room temperature, followed by washing and incubation with specific antibodies at 4 °C overnight (Table 2). After washing with TBST 3 times, the secondary antibody was incubated at room temperature for 2 h. The bands were detected using a chemiluminescence detection system (Fujifilm, Tokyo, Japan, and quantified using ImageJ software (National Institutes of Health, Bethesda, MD, USA). Cells from the untreated control (CON) group were used as the reference sample, and β-actin served as the internal loading control for the normalization of protein expression.

2.9. Immunofluorescence Analysis

IF was performed as previously described [40]. GCs were seeded onto cover slips in 6-well plates and treated as mentioned above. After treatment for a specific time, cells were fixed in 4% paraformaldehyde (Beyotime Biotech, Shanghai, China) for 12 h and blocked with 5% bovine serum albumin (Solarbio, Beijing, China). The cells were then incubated overnight at 4 °C with primary antibodies against Caspase-1 or GSDMD (1:200 dilution), and subsequently with 594-conjugated donkey anti-rabbit secondary antibody (1:500 dilution, Bioss, Beijing, China) for 1 h at room temperature in the dark. Nuclei were counterstained with DAPI (1 μg/mL for 5 min, Solarbio, Beijing, China). The negative control was incubated with PBS instead of the primary antibody. Images were captured using a fluorescence microscope (Nikon, Japan) and quantified using ImageJ software (National Institutes of Health, MD, USA).

2.10. Statistical Analysis

All experiments were performed independently, using GCs, which are isolated from at least three different goats (n = 3 biological replicates), with each treatment conducted in at least triplicate wells (technical replicates). Data are expressed as mean ± SEM to reflect experimental reproducibility. The t-test was used to evaluate the significance between the two groups. Statistical differences were considered to be significant at p < 0.05.

3. Results

3.1. Effect of Different LPS Concentrations and Times on Goat GCs

To establish an inflammatory model of goat GCs, cells were first exposed to different concentrations of LPS for 12 h. As shown in Figure 1A, different concentrations of LPS (2, 4, 8, 16 μg/mL) had no effect on the viability of GCs (p > 0.05). However, LPS at 4–16 μg/mL increased the MDA content (p < 0.05, Figure 1B), and reduced SOD activity and T-AOC content (p < 0.05, Figure 1C,D). Different concentrations (2–16 μg/mL) of LPS significantly increased ROS production (p < 0.05, Figure 1E). Furthermore, LPS at 4 μg/mL significantly increased all the mRNA abundances of IL-1β, IL-6, and TNF-α (Figure 1F), as well as GSDMD, Caspase1, and NLRP3 (p < 0.05, Figure 1G).
Regarding the time effect (0, 6, 12, 18, and 24 h), LPS treatment for 12–24 h at 4 μg/mL upregulated the mRNA abundances of IL-1β, IL-6, GSDMD, and NLRP3 (p < 0.05, Figure 1H). Therefore, the LPS treatment at 4 μg/mL for 12 h was applied for further experiments.

3.2. Effect of Different RES Concentrations and Times on Goat GCs

To optimize the concentration and treatment time of RES alleviating the LPS effect, GCs were first treated with RES (0, 0.1, 1, 5, and 10 μM) for 12 h, and results showed that RES at 5 or 10 μM significantly reduced the cell viability (p < 0.05, Figure 2A). Therefore, cells were pretreated with RES at 0.1 or 1 μM, followed by LPS exposure at 4 μg/mL for 12 h to detect the expression of genes related to inflammation and pyroptosis. LPS-induced gene expression levels of IL-1β, IL-6, TNF-α, GSDMD, Caspase1, and NLRP3 were all significantly reduced by pretreatment with 1 μM RES (p < 0.05, Figure 2B,C).
Similarly, different pretreatment times (0, 6, 12, 18, and 24 h) were set with 1 μM RES., and results showed that treatment with RES for 24 h significantly reduced cell viability (p < 0.05, Figure 2D). Therefore, cells were pretreated with RES for 6–18 h, followed by exposure to LPS, and results showed that LPS exposure increased the gene expression levels of IL-1β, IL-6, TNF-α, GSDMD, Caspase1, and NLRP3, which were all significantly reduced by pretreatment with 1 μM RES for 6 h (p < 0.05, Figure 2E,F). Hence, the RES treatment at 1 μM for 6 h was applied for the further experiment.

3.3. Effect of Different GW9662 Concentrations and Times on Goat GCs

To optimize the concentration and treatment time of GW9662 to block the effect of RES on LPS, GCs were first treated with GW9662, ranging from 0 to 20 μM for 12 h. The results showed that 10 or 20 μM GW9662 significantly decreased cell viability (p < 0.05, Figure 3A). Therefore, cells were pretreated with GW9662 at concentrations of 0.1, 1, and 5 μM for 12 h, followed by the addition of RES (1 μM for 6 h) or/and LPS (4 μg/mL for 12 h) to detect the expression of PPARG, and genes related to inflammation and pyroptosis. Results showed that RES reversed the LPS-induced decrease in PPARG expression, which was blocked by GW9662 (1 or 5 μM) (p < 0.05, Figure 3B). RES inhibited LPS-induced increases in the expression of IL-1β, IL-6, TNF-α, NLRP3, Caspase-1, and GSDMD, which were all reversed by GW9662 (1 or 5 μM) (p < 0.05, Figure 3C,D). Therefore, a concentration of 1 μM was selected for time screening, based on the results.
Then, GCs were treated with 1 μM GW9662 for 0 to 24 h, and GW9662 treatment for 24 h decreased cell viability (p < 0.05, Figure 3E). Therefore, cells were pretreated with GW9662 at 1 μM for 6, 12, and 18 h, followed by exposure to RES (1 μM for 6 h) or/and LPS (4 μg/mL for 12 h). Results showed that RES reversed the LPS-induced decrease in PPARG expression (p < 0.05, Figure 3F) and increases in the expressions of IL-1β, IL-6, TNF-α, NLRP3, Caspase1, and GSDMD, all of which were blocked by GW9662 for 12 or 18 h (p < 0.05, Figure 3G,H). Therefore, the 12 h of GW9662 treatment at 1 μM was chosen in further experiments.

3.4. Resveratrol Alleviates the Effect of LPS on Oxidative Stress in Goat GCs by Activating PPARG

To investigate whether RES alleviates the effect of LPS on the oxidative stress of goat GCs through PPARG, GCs were assigned to four groups to detect the oxidative indexes. Results showed that RES significantly decreased the LPS-induced increase in the MDA content (p < 0.05, Figure 4A) and decreased it in the SOD activity and T-AOC content (p < 0.05, Figure 4B,C). Compared with the LPS group, RES pretreatment significantly increased the gene and protein expression levels of SOD (p < 0.05, Figure 4D–F) and reduced the fluorescence intensity of ROS (p < 0.05, Figure 4G,H). GW9662 reversed these effects, suggesting that the effects of RES were PPARG-dependent.

3.5. Resveratrol Alleviates the Effect of LPS on Inflammation and Pyroptosis in Goat GCs by Activating PPARG

To investigate whether RES alleviates the effects of LPS on inflammation and pyroptosis in goat GCs through PPARG, GCs were assigned to four groups to detect the expression of related genes and proteins. The results showed that RES pretreatment significantly decreased the LPS-induced gene and protein expressions of IL-1β (p < 0.05, Figure 5A–C), gene expression levels of NLRP3, Caspase-1, and GSDMD, as well as the protein level of GSDMD (p < 0.05, Figure 5D–F). However, all these effects were reversed by GW9662, which is a selective PPARG antagonist. The protein expressions of Caspase-1 and GSDMD were further confirmed by IF staining. Results showed that RES pretreatment significantly reduced the protein intensities of Caspase1 and GSDMD, which were blocked by GW9662 (p < 0.05, Figure 5G,H), suggesting that PPARG is involved in inflammation and pyroptosis regulation.

3.6. Resveratrol Alleviates the Effect of LPS on the Steroidogenesis of Goat GCs by Activating PPARG

To investigate whether RES alleviates the effect of LPS on the steroidogenesis of goat GCs through PPARG, GCs were assigned to four groups to detect the E2 level and steroidogenic gene and protein expression. Results showed that compared with the LPS group, RES pretreatment increased the content of E2 (p < 0.05, Figure 6A) and the mRNA abundances of CYP19A1 and HSD3B, as well as HSD3B protein expression (p < 0.05, Figure 6B–D), which were all blocked by GW9662.

3.7. Resveratrol Alleviates the Effect of LPS on Goat GCs by Activating the PPARG/NRF2/HO-1 Signaling Pathway

To explore the possible regulatory mechanism of RES, the expression levels of PPARG, NRF2, and HO-1 were measured. Pretreatment with RES significantly increased the gene and protein expressions of PPARG, NRF2, and HO-1 compared with the LPS group, while GW9662 significantly inhibited these upregulations (p < 0.05, Figure 7A–C).

4. Discussion

4.1. Effects of Resveratrol on LPS-Induced Oxidative Stress, Inflammation, and Pyroptosis in Goat Granulosa Cells

In the current study, we found that RES alleviates the effect of LPS on oxidative stress, inflammation, pyroptosis, and estrogen synthesis in GCs by activating the PPARG/NRF2/HO-1 signaling pathway.
To establish the GCs inflammation model, cells were exposed to different concentrations and times of LPS. LPS at 4 μg/mL for 12 h increased the gene expressions of IL-1β, IL-6, and TNF-α, as well as GSDMD, Caspase1, and NLRP3. Previous studies have shown that exposure to LPS at 1 μg/mL for 24 h caused endoplasmic reticulum stress by increasing the expression of the above inflammatory genes in mouse GCs [41], LPS at 0.1 μg/mL for 24 h increased the gene expressions of IL-1β and TNF-α in cow GCs [42], and LPS at 10 μM for 24 h increased the expression of NLRP3, caspase-1, and GSDMD in human granulosa-like tumor cell lines [43]. Therefore, the different dosage and time effects of LPS on GCs might be due to the animal species.
To investigate the rescue effect of RES on LPS in GCs, the concentrations and times were screened by detecting inflammation and pyroptosis indicators, and pretreatment with RES at 1 μM for 6 h reduced the expressions of IL-1β, IL-6, TNF-α, GSDMD, Caspase1, and NLRP3. Previous studies have shown that RES at 20 or 100 μM for 24 h protected luteinized GCs from hydrogen peroxide in rat ovaries [44]. RES at 5 μM for 24 h inhibited NLRP3 inflammasome activation and macrophage pyroptosis by increasing the expressions of TNF-α, IL-1β, and IL-6 in mice GCs [45]. RES at 30, 15, and 7.5 μM inhibited the activation of NLRP3 inflammasomes and pyroptosis of macrophages by reducing the levels of IL-1β and Caspase-1 in rats exposed to monosodium urate [46]. Therefore, the effect of RES dosage and time on inflammation and pyroptosis might depend on cell types or animal species.
To investigate the mechanism of RES alleviating the impact of LPS on GCs, GW9662 (an antagonist of PPARG) was applied. It was found that GW9662 at 1 μM for 12 h blocked the effect of RES on the inflammatory (IL-1β, IL-6, TNF-α) and pyroptosis (GSDMD, Caspase1, and NLRP3) gene expressions. It was reported that Berberine upregulated PPARG to inhibit the expressions of NLPR3, Caspase1, and GSDMD, which can be blocked by GW9662 (10 μM for 6 h) in mice [47]. Salvianolactone acid A partially alleviated an acute lung injury by reducing the expression of NLRP3 and IL-1β, which was blocked by GW9662 (1 μM for 24 h) [16]. Therefore, the effect of GW9662 treatment concentration and time might be different in various cell types.
The specific concentration and duration of the drugs were then applied to investigate the effect and mechanism of RES that alleviated the effect of LPS in goat GCs. The current increase in MDA content, as well as decreases in SOD activity and T-AOC content induced by LPS, were consistent with the findings of a study in mice that demonstrated that LPS can increase MDA content and decrease the SOD activity and T-AOC level [48]. The present alleviation effect of RES on the alterations of the SOD activity, as well as MDA and T-AOC content induced by LPS, was consistent with that in a mouse diabetic retinopathy model [49], and in fishes exposed to ammonia [50]. Furthermore, GW9662 blocked the alleviation of RES on the LPS in oxidative indexes, which is consistent with the study by Liu et al., who found that GW9662 protected mice from hepatic ischemia/reperfusion injury by aggravating oxidative stress [51]. All these indicate that RES can alleviate the effect of LPS on oxidative stress in goat GCs by activating the PPARG signal.
LPS can cause ROS production, which can damage the structure and function of cell membranes [52]. RES can directly react with multiple ROS free radicals, reducing oxidative damage to intracellular biological macromolecules [53]. Moreira-Pinto et al. [54] treated human GCs with different RES concentrations for different durations and found that low doses of RES could alleviate ROS production. The current increase in ROS, induced by LPS in goat GCs, was reduced by RES, which was blocked by GW9662; this is consistent with the study that GW9662 blocked the effect of Astragaloside IV-induced PPARG in intestinal epithelial cells and reduction in ROS production [55]. Therefore, RES can alleviate the effect of LPS on the ROS content in goat GCs by activating the PPARG signal.
The current LPS-stimulated expressions of IL-1β, TNF-α, and IL-6, reduced by RES, which were blocked by GW9662, are consistent with previous studies. Chen et al. found that LPS enhanced the expressions of IL-1β, TNF-α, and IL-6 in neonates with sepsis [56]. RES induced a dose-dependent inhibition of IL-1β, IL-6, and TNF-α production in T cells [57]. RES also reduced the expression of IL-6, IL-1β, and TNF-α induced by Mycoplasma gallisepticum, both in vivo and in vitro [58]. GW9662 reversed the protective effect of docosahexaenoic acid on bovine mammary epithelial cells exposed to LPS, and increased the expressions of TNF-α, IL-6, and IL-1β [59]. Taken together, RES alleviates the effect of LPS on the inflammation of goat GCs by activating the PPARG signal.
The current LPS-stimulated expressions of NLRP3, Caspase1, and GSDMD were reversed by RES and were blocked by GW9662, which is consistent with previous studies. Wei et al. found that LPS increased cell membrane permeability mediated by GSDMD, resulting in pyroptosis in rats [60]. Luo et al. reported that bergapten inhibits NLRP3 inflammasome activation and LPS-induced pyroptosis in rat J774A.1 cell line [61]. Consistent with our findings, RES improved gouty arthritis, which might inhibit NLRP3 inflammasomes in rats [62]. Magnolol reduced the GSDMD gene expression through PPARG; however, GW9662 could block the reduction [63]. Taken together, RES can alleviate the effect of LPS on pyroptosis in goat GCs by activating the PPARG signal.
HSD3B is a steroid-metabolizing enzyme that is widely present in the synthetic pathways of steroid hormones and can catalyze the transformation of various steroid substrates [64]. CYP19A1 is a member of the cytochrome P450 superfamily, and a key enzyme involved in estrogen synthesis [65]. The current reduction in estrogen secretion accompanied by HSD3B and CYP19A1 expression was alleviated by RES, which was blocked by GW9662. Consistent with our findings, LPS reduced CYP19A1 expression in bovine GCs from large follicles and luteal HSD3B expression in cattle and cows [66]. RES treatment increased the level of HSD3B in Leydig cell lines in mice [67], alleviated high-glucose-induced inhibition of steroidogenesis and the expressions of CYP19A1 and HSD3B in mouse GCs [68]. GW9662 reduces PPARG and HSD3B expression in human GCs [69]. All these indicate that RES can alleviate the effect of LPS on hormone synthesis in goat GCs by activating the PPARG signal.

4.2. Involvement of the PPARG/NRF2/HO-1 Pathway and Physiological Implications

Furthermore, the PPARG signaling pathway, which is involved in the regulation of cellular oxidative stress, inflammation, and pyroptosis, was explored. Previous studies have demonstrated that RES can upregulate PPARG expression in mouse MIN6 cells [70] and regulate the expressions of NRF2 and HO-1 expression in human ovaries [31]. All these studies are consistent with our current findings, which demonstrate that RES alleviates the LPS-induced reduction in PPARG/NRF2/HO-1 expression. When GW9662 was added, the expression of PPARG decreased, and the expressions of NRF2 and HO-1 also declined in mouse hearts [71]. This is consistent with the current inhibition by GW9662 in the expression of PPARG mediated by RES, as well as the expression of its downstream genes. Given that PPARG inhibitors have an impact on estrogen synthesis, oxidative stress, inflammation, and pyroptosis, it is possible that they exert regulation through the PPARG/NRF2/HO-1 pathway.
Despite the current results showing that the RES reduces the oxidative stress and pyroptosis caused by LPS through the PPARG/NRF2/HO-1 signaling pathway, the molecular process of intracellular penetration and receptor engagement of RES is yet to be elucidated. The literature suggests that RES is able to interact with the ligand-binding domain of PPARG and increase the transcriptional regulation of antioxidant and anti-inflammatory genes [20,31]. It is also possible that RES can regulate mitochondrial and endoplasmic-reticulum homeostasis, which results in lowering the accumulation of ROS and the activation of inflammasomes. In order to understand these mechanisms in goat GCs, further studies through receptor-binding and molecular-docking techniques are justified. A limitation of this study is that the reproductive stage of the animals could not be determined, because ovarian samples were collected post-slaughter, without hormonal or ultrasonographic evaluation. Future studies should include reproductive-cycle assessment to minimize physiological variation.

5. Conclusions

The present study proved that LPS exposure caused significant oxidative stress, inflammation, and pyroptosis, leading to decreased estrogen synthesis in goat granulosa cells. Resveratrol (RES) treatment effectively reversed these effects by increasing antioxidant enzyme activities, reducing reactive oxygen species and inflammatory cytokine levels, and improving steroidogenic gene expression. These protective effects were mediated through the activation of the PPARG/NRF2/HO-1 signaling pathway, as confirmed by the inhibitory effects of GW9662 on RES-induced protection.
Overall, this work provides clear mechanistic evidence that RES mitigates LPS-induced oxidative and inflammatory damage in granulosa cells through PPARG/NRF2/HO-1 activation. These findings suggest that RES could serve as a potential nutritional or therapeutic approach to protect ovarian function and fertility against inflammation-related reproductive disorders in ruminants.

Author Contributions

J.Z.: Conceptualization, Methodology, Data curation, Formal analysis, Validation, Writing. X.Z.: Software, Visualization. Z.C.: Resources, Visualization. X.L.: Resources, Visualization. M.T.: Writing—review and editing; D.M.: Conceptualization, Methodology, Supervision, Funding acquisition, Writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the National Natural Science Foundation of China (32072727).

Institutional Review Board Statement

Ethical review and approval were waived for this study because goat ovaries were obtained from healthy adult animals at a licensed slaughterhouse as by-products of routine processing. No animals were killed specifically for this research. The collection and handling of animal-derived materials followed the ethical standards and animal welfare requirements of Nanjing Agricultural University, under license number (SYXK 2022-0031).

Informed Consent Statement

Not applicable.

Data Availability Statement

Data will be made available on request.

Conflicts of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Abbreviations

The following abbreviations are used in this manuscript:
Caspase-1Cysteine–aspartic acid protease 1
CCK8Cell counting kit-8
CYP19A1Cytochrome P450 family 19 subfamily A member 1
E2Estradiol
GCsGranulosa cells
GSDMDGasdermin D
GW9662 PPARG antagonist
H&E Hematoxylin and eosin
HO-1Heme oxygenase 1
HSD3B Hydroxysteroid dehydrogenase 3 beta
IFImmunofluorescence
IL-1β Interleukin-1β
IL-6Interleukin-6
LPSLipopolysaccharide
MDAMalondialdehyde
NLRP3Nucleotide-binding oligomerization domain-like receptor protein 3
NRF2 Nuclear factor erythroid 2-related factor 2
PPARGPeroxisome proliferator-activated receptor gamma
RIARadioimmunoassay
ROSReactive oxygen species
RT-qPCRReal-time quantitative polymerase chain reaction
SODSuperoxide dismutase
T-AOCTotal antioxidant capacity
TG Triglycerides
TNF-αTumor necrosis factor-alpha
WBWestern blot

References

  1. Agarwal, A.; Gupta, S.; Sharma, R.K. Role of oxidative stress in female reproduction. Reprod. Biol. Endocrinol. 2012, 10, 49. [Google Scholar] [CrossRef]
  2. Rizzo, A.; Sciorsci, R.L.; Mutinati, M. Oxidative stress in bovine and ovine reproduction: Physiological roles and pathological mechanisms. Theriogenology 2021, 173, 186–195. [Google Scholar] [CrossRef]
  3. Lei, Z.; Lu, W.; Hu, X.; Wang, X.; Li, C. Lipopolysaccharide-induced inflammatory injury in bovine granulosa cells is mediated by the TLR4/NF-κB pathway. Anim. Reprod. Sci. 2019, 207, 16–24. [Google Scholar] [CrossRef]
  4. Shi, Y.Q.; Zhu, X.T.; Zhang, S.N.; Ma, Y.F.; Han, Y.H.; Jiang, Y.; Zhang, Y.H. Premature ovarian insufficiency: A review on the role of oxidative stress and the application of antioxidants. Front. Endocrinol. 2023, 14, 1172481. [Google Scholar] [CrossRef] [PubMed]
  5. Liu, H.; Jin, L.; Wang, X.; Shi, J.; He, Y.; Sun, N.; Yang, F. Reactive oxygen species in polycystic ovary syndrome: Mechanistic insights into pathogenesis and therapeutic opportunities. Redox Biol. 2025, 85, 103776. [Google Scholar] [CrossRef] [PubMed]
  6. Dai, M.; Hong, L.; Yin, T.; Liu, S. Disturbed follicular microenvironment in polycystic ovary syndrome: Relationship to oocyte quality and infertility. Endocrinology 2024, 165, bqae023. [Google Scholar] [CrossRef]
  7. Zeng, Y.; Wang, C.; Yang, C.; Shan, X.; Meng, X.Q.; Zhang, M. Unveiling the role of chronic inflammation in ovarian aging: Insights into mechanisms and clinical implications. Hum. Reprod. 2024, 39, 1599–1607. [Google Scholar] [CrossRef]
  8. Sul, O.-J.; Ra, S.W. Quercetin prevents LPS-induced oxidative stress and inflammation by modulating NOX2/ROS/NF-kB in lung epithelial cells. Molecules 2021, 26, 6949. [Google Scholar] [CrossRef]
  9. Park, H.J.; Gholam Zadeh, M.; Suh, J.H.; Choi, H.S. Dauricine protects from LPS-induced bone loss via the ROS/PP2A/NF-kappaB axis in osteoclasts. Antioxidants 2020, 9, 588. [Google Scholar] [CrossRef]
  10. Lv, L.; Lv, L.; Zhang, Y.; Kong, Q. Luteolin prevents LPS-induced TNF-alpha expression in cardiac myocytes through inhibiting NF-kappaB signaling pathway. Inflammation 2011, 34, 620–629. [Google Scholar] [CrossRef]
  11. Liu, Z.; Wang, M.; Wang, X.; Bu, Q.; Wang, Q.; Su, W.; Li, L.; Zhou, H.; Lu, L. XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury. Redox Biol. 2022, 52, 102305. [Google Scholar] [CrossRef]
  12. Vestergaard, M.; Ingmer, H. Antibacterial and antifungal properties of resveratrol. Int. J. Antimicrob. Agents 2019, 53, 716–723. [Google Scholar] [CrossRef]
  13. Ratz-Łyko, A.; Arct, J. Resveratrol as an active ingredient for cosmetic and dermatological applications: A review. J. Cosmet. Laser Ther. 2019, 21, 84–90. [Google Scholar] [CrossRef]
  14. Zhou, D.D.; Luo, M.; Huang, S.Y.; Saimaiti, A.; Shang, A.; Gan, R.Y.; Li, H.B. Effects and mechanisms of resveratrol on aging and age-related diseases. Oxidative Med. Cell. Longev. 2021, 2021, 9932218. [Google Scholar] [CrossRef]
  15. Huo, Y.; Yang, D.; Lai, K.; Tu, J.; Zhu, Y.; Ding, W.; Yang, S. Antioxidant effects of resveratrol in intervertebral disk. J. Investig. Surg. 2022, 35, 1135–1144. [Google Scholar] [CrossRef]
  16. Malaguarnera, L. Influence of resveratrol on the immune response. Nutrients 2019, 11, 946. [Google Scholar] [CrossRef]
  17. Li, Y.; Zhou, D.; Ren, Y.; Zhang, Z.; Guo, X.; Ma, M.; Xue, Z.; Lv, J.; Liu, H.; Xi, Q.; et al. Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1. Autophagy 2019, 15, 478–492. [Google Scholar] [CrossRef]
  18. Gosseaume, C.; Fournier, T.; Jéru, I.; Vignaud, M.L.; Missotte, I.; Archambeaud, F.; Debussche, X.; Droumaguet, C.; Fève, B.; Grillot, S.; et al. Perinatal, metabolic, and reproductive features in PPARG-related lipodystrophy. Eur. J. Endocrinol. 2023, 188, 273–281. [Google Scholar] [CrossRef]
  19. Chang, Y.H.; Duong, D.M.; Goll, J.B.; Wood, D.C.; Jensen, T.L.; Yin, L.; Gelber, C.E.; Seyfried, N.T.; Anderson, E.; Natrajan, M.S.; et al. Proteomic analysis of human immune responses to live-attenuated tularemia vaccine. Vaccines 2020, 8, 413. [Google Scholar] [CrossRef]
  20. Zhang, Q.; Zeng, M.; Zhang, B.; Ren, Y.; Li, S.; Wang, R.; Hu, Y.; Fan, R.; Wang, M.; Yu, X.; et al. Salvianolactone acid A isolated from Salvia miltiorrhiza ameliorates lipopolysaccharide-induced acute lung injury in mice by regulating PPAR-gamma. Phytomedicine 2022, 105, 154386. [Google Scholar] [CrossRef]
  21. Ruan, G.Y.; Ye, L.X.; Lin, J.S.; Lin, H.Y.; Yu, L.R.; Wang, C.Y.; Mao, X.D.; Zhang, S.H.; Sun, P.M. An integrated approach of network pharmacology, molecular docking, and experimental verification uncovers kaempferol as the effective modulator of HSD17B1 for treatment of endometrial cancer. J. Transl. Med. 2023, 21, 204. [Google Scholar] [CrossRef]
  22. Li, T.; Zhang, L.; Jin, C.; Xiong, Y.; Cheng, Y.Y.; Chen, K. Pomegranate flower extract bidirectionally regulates the proliferation, differentiation and apoptosis of 3T3-L1 cells through regulation of PPARgamma expression mediated by PI3K-AKT signaling pathway. Biomed. Pharmacother. 2020, 131, 110769. [Google Scholar] [CrossRef]
  23. Tsai, M.L.; Chen, H.Y.; Tseng, M.C.; Chang, R.C. Cloning of peroxisome proliferators activated receptors in the cobia (Rachycentron canadum) and their expression at different life-cycle stages under cage aquaculture. Gene 2008, 425, 69–78. [Google Scholar] [CrossRef]
  24. Aguirre, L.; Fernández-Quintela, A.; Arias, N.; Portillo, M.P. Resveratrol: Anti-obesity mechanisms of action. Molecules 2014, 19, 18632–18655. [Google Scholar] [CrossRef]
  25. Shahcheraghi, S.H.; Salemi, F.; Small, S.; Syed, S.; Salari, F.; Alam, W.; Cheang, W.S.; Saso, L.; Khan, H. Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospects. Phytother. Res. 2023, 37, 1590–1605. [Google Scholar] [CrossRef]
  26. Cataldi, S.; Aprile, M.; Melillo, D.; Mucel, I.; Giorgetti-Peraldi, S.; Cormont, M.; Italiani, P.; Blüher, M.; Tanti, J.F.; Ciccodicola, A.; et al. TNFα mediates inflammation-induced effects on PPARG splicing in adipose tissue and mesenchymal precursor cells. Cells 2021, 11, 42. [Google Scholar] [CrossRef]
  27. Meng, T.; Xiao, D.; Muhammed, A.; Deng, J.; Chen, L.; He, J. Anti-inflammatory action and mechanisms of resveratrol. Molecules 2021, 26, 229. [Google Scholar] [CrossRef]
  28. Shah, M.A.; Haris, M.; Faheem, H.I.; Hamid, A.; Yousaf, R.; Rasul, A.; Shah, G.M.; Khalil, A.A.; Wahab, A.; Khan, H.; et al. Cross-talk between obesity and diabetes: Introducing polyphenols as an effective phytomedicine to combat the dual sword diabesity. Curr. Pharm. Des. 2022, 28, 1523–1542. [Google Scholar] [CrossRef]
  29. Yu, X.; Jia, Y.; Ren, F. Multidimensional biological activities of resveratrol and its prospects and challenges in the health field. Front. Nutr. 2024, 11, 1408651. [Google Scholar] [CrossRef]
  30. Palomera-Avalos, V.; Griñán-Ferré, C.; Izquierdo, V.; Camins, A.; Sanfeliu, C.; Canudas, A.M.; Pallàs, M. Resveratrol modulates response against acute inflammatory stimuli in aged mouse brain. Exp. Gerontol. 2018, 102, 3–11. [Google Scholar] [CrossRef]
  31. Sadeghi, A.; Seyyed Ebrahimi, S.S.; Golestani, A.; Meshkani, R. Resveratrol ameliorates palmitate-induced inflammation in skeletal muscle cells by attenuating oxidative stress and JNK/NF-kappaB pathway in a sirt1-independent mechanism. J. Cell Biochem. 2017, 118, 2654–2663. [Google Scholar] [CrossRef]
  32. Zou, T.; Ma, L.; Gu, L.; Xi, S.; Zhang, K.; Guo, X. Role of Wnt/beta-catenin signaling pathway in ameloblast differentiation in relevance to dental fluorosis. Chem. Biol. Interact. 2022, 367, 110145. [Google Scholar] [CrossRef]
  33. Xie, Z.; Ying, Q.; Luo, H.; Qin, M.; Pang, Y.; Hu, H.; Zhong, J.; Song, Y.; Zhang, Z.; Zhang, X. Resveratrol alleviates retinal ischemia-reperfusion injury by inhibiting the NLRP3/Gasdermin D/Caspase-1/Interleukin-1beta pyroptosis pathway. Investig. Ophthalmol. Vis. Sci. 2023, 64, 28. [Google Scholar] [CrossRef]
  34. Lai, W.; Yu, L.; Deng, Y. PPARgamma alleviates preeclampsia development by regulating lipid metabolism and ferroptosis. Commun. Biol. 2024, 7, 429. [Google Scholar] [CrossRef]
  35. Su, N.; Zhao, Y.; Zhang, C.; He, Y.; Peng, C.; Liu, B.; Zhao, C.; Hu, X.; Fu, Y.; Liu, Y.; et al. Subacute ruminal acidosis induces hepatic injury in dairy goats via oxidative stress and ferritinophagy-ferroptosis axis. Int. Immunopharmacol. 2025, 161, 115026. [Google Scholar] [CrossRef]
  36. Plaizier, J.; Khafipour, E.; Li, S.; Gozho, G.N.; Krause, D.O. Subacute ruminal acidosis (SARA), endotoxins and health consequences. Anim. Feed. Sci. Technol. 2012, 172, 9–21. [Google Scholar] [CrossRef]
  37. Zhang, M.; Yu, H.; Wang, W.; Wang, F.; Mao, D. Effects of LPS on lipid droplet accumulation, proliferation, and steroidogenesis in goat luteinized granulosa cells. J. Biochem. Mol. Toxicol. 2019, 33, e22329. [Google Scholar] [CrossRef]
  38. Zhao, J.; Xu, Y.; Yu, H.; Li, X.; Wang, W.; Mao, D. Effects of PPARG on the proliferation, apoptosis, and estrogen secretion in goat granulosa cells. Theriogenology 2025, 231, 62–72. [Google Scholar] [CrossRef]
  39. Lei, L.; Ge, J.; Zhao, H.; Wang, X.; Yang, L. Role of endoplasmic reticulum stress in lipopolysaccharide-inhibited mouse granulosa cell estradiol production. J. Reprod. Dev. 2019, 65, 459–465. [Google Scholar] [CrossRef]
  40. Yamamoto, N.; Takeuchi, H.; Yamaoka, M.; Nakanishi, T.; Tonai, S.; Nishimura, R.; Morita, T.; Nagano, M.; Kameda, S.; Genda, K.; et al. Lipopolysaccharide (LPS) suppresses follicle development marker expression and enhances cytokine expressions, which results in fail to granulosa cell proliferation in developing follicle in cows. Reprod. Biol. 2023, 23, 100710. [Google Scholar] [CrossRef]
  41. Zhou, L.H.; Zou, H.; Hao, J.Y.; Huang, Y.; Zhang, J.N.; Xu, X.H.; Li, J. Metformin inhibits ovarian granular cell pyroptosis through the miR-670-3p/NOX2/ROS pathway. Aging 2023, 15, 4429–4443. [Google Scholar] [CrossRef]
  42. Cai, M.; Sun, H.; Huang, Y.; Yao, H.; Zhao, C.; Wang, J.; Zhu, H. Resveratrol protects rat ovarian luteinized granulosa cells from H2O2-induced dysfunction by activating autophagy. Int. J. Mol. Sci. 2023, 24, 10914. [Google Scholar] [CrossRef]
  43. Yuan, B.; Luo, S.; Feng, L.; Wang, J.; Mao, J.; Luo, B. Resveratrol regulates the inflammation and oxidative stress of granulosa cells in PCOS via targeting TLR2. J. Bioenerg. Biomembr. 2022, 54, 191–201. [Google Scholar] [CrossRef]
  44. Fan, W.; Chen, S.; Wu, X.; Zhu, J.; Li, J. Resveratrol Relieves Gouty Arthritis by Promoting Mitophagy to Inhibit Activation of NLRP3 Inflammasomes. J. Inflamm. Res. 2021, 14, 3523–3536. [Google Scholar] [CrossRef]
  45. Zhao, Y.; Li, Z.; Lu, E.; Sheng, Q.; Zhao, Y. Berberine exerts neuroprotective activities against cerebral ischemia/reperfusion injury through up-regulating PPAR-gamma to suppress NF-kappaB-mediated pyroptosis. Brain Res. Bull. 2021, 177, 22–30. [Google Scholar] [CrossRef]
  46. Zhou, M.; Xu, W.; Wang, J.; Yan, J.; Shi, Y.; Zhang, C.; Ge, W.; Wu, J.; Du, P.; Chen, Y. Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-kappaB pathway quenches intestinal inflammation and oxidative stress injury. EBioMedicine 2018, 35, 345–360. [Google Scholar] [CrossRef] [PubMed]
  47. Yuan, D.; Xu, Y.; Xue, L.; Zhang, W.; Gu, L.; Liu, Q. Resveratrol protects against diabetic retinal ganglion cell damage by activating the Nrf2 signaling pathway. Heliyon 2024, 10, e30786. [Google Scholar] [CrossRef] [PubMed]
  48. Wu, L.; Chen, Q.; Dong, B.; Han, D.; Zhu, X.; Liu, H.; Yang, Y.; Xie, S.; Jin, J. Resveratrol attenuated oxidative stress and inflammatory and mitochondrial dysfunction induced by acute ammonia exposure in gibel carp (Carassius gibelio). Ecotoxicol. Environ. Saf. 2023, 251, 114544. [Google Scholar] [CrossRef]
  49. Liu, X.; Zhang, P.; Song, X.; Cui, H.; Shen, W. PPARgamma mediates protective effect against hepatic ischemia/reperfusion injury via NF-kappaB pathway. J. Investig. Surg. 2022, 35, 1648–1659. [Google Scholar] [CrossRef]
  50. Wu, D.; Liang, S.; Du, X.; Xiao, J.; Feng, H.; Ren, Z.; Yang, X.; Yang, X. Effects of fecal microbiota transplantation and fecal virome transplantation on LPS-induced intestinal injury in broilers. Poult. Sci. 2024, 103, 103316. [Google Scholar] [CrossRef] [PubMed]
  51. Kumar, B.; Iqbal, M.A.; Singh, R.K.; Bamezai, R.N. Resveratrol inhibits TIGAR to promote ROS induced apoptosis and autophagy. Biochimie 2015, 118, 26–35. [Google Scholar] [CrossRef]
  52. Moreira-Pinto, B.; Costa, L.; Felgueira, E.; Fonseca, B.M.; Rebelo, I. Low doses of resveratrol protect human granulosa cells from induced-oxidative stress. Antioxidants 2021, 10, 516. [Google Scholar] [CrossRef] [PubMed]
  53. Liang, J.; Yang, C.; Li, P.; Zhang, M.; Xie, X.; Xie, X.; Chen, Y.; Wang, Q.; Zhou, L.; Luo, X. Astragaloside IV inhibits AOM/DSS-induced colitis-associated tumorigenesis via activation of PPARgamma signaling in mice. Phytomedicine 2023, 121, 155116. [Google Scholar] [CrossRef]
  54. Chen, X.F.; Wu, J.; Zhang, Y.D.; Zhang, C.X.; Chen, X.T.; Sun, J.H.; Chen, T.X. Role of Zc3h12a in enhanced IL-6 production by newborn mononuclear cells in response to lipopolysaccharide. Pediatr. Neonatol. 2018, 59, 288–295. [Google Scholar] [CrossRef]
  55. Fuggetta, M.P.; Bordignon, V.; Cottarelli, A.; Macchi, B.; Frezza, C.; Cordiali-Fei, P.; Ensoli, F.; Ciafrè, S.; Marino-Merlo, F.; Mastino, A.; et al. Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol. J. Exp. Clin. Cancer Res. 2016, 35, 118. [Google Scholar] [CrossRef]
  56. Zou, M.; Yang, W.; Niu, L.; Sun, Y.; Luo, R.; Wang, Y.; Peng, X. Polydatin attenuates Mycoplasma gallisepticum (HS strain)-induced inflammation injury via inhibiting the TLR6/MyD88/NF-kappaB pathway. Microb. Pathog. 2020, 149, 104552. [Google Scholar] [CrossRef] [PubMed]
  57. He, X.; Liu, W.; Shi, M.; Yang, Z.; Zhang, X.; Gong, P. Docosahexaenoic acid attenuates LPS-stimulated inflammatory response by regulating the PPARgamma/NF-kappaB pathways in primary bovine mammary epithelial cells. Res. Vet. Sci. 2017, 112, 7–12. [Google Scholar] [CrossRef] [PubMed]
  58. Wei, C.; Jiang, W.; Wang, R.; Zhong, H.; He, H.; Gao, X.; Zhong, S.; Yu, F.; Guo, Q.; Zhang, L.; et al. Brain endothelial GSDMD activation mediates inflammatory BBB breakdown. Nature 2024, 629, 893–900. [Google Scholar] [CrossRef]
  59. Luo, T.; Jia, X.; Feng, W.D.; Wang, J.Y.; Xie, F.; Kong, L.D.; Wang, X.J.; Lian, R.; Liu, X.; Chu, Y.J.; et al. Bergapten inhibits NLRP3 inflammasome activation and pyroptosis via promoting mitophagy. Acta Pharmacol. Sin. 2023, 44, 1867–1878. [Google Scholar] [CrossRef]
  60. Wang, N.; Kong, R.; Han, W.; Bao, W.; Shi, Y.; Ye, L.; Lu, J. Honokiol alleviates ulcerative colitis by targeting PPAR-gamma-TLR4-NF-kappaB signaling and suppressing gasdermin-D-mediated pyroptosis in vivo and in vitro. Int. Immunopharmacol. 2022, 111, 109058. [Google Scholar] [CrossRef]
  61. King, S.R.; LaVoie, H.A. Gonadal transactivation of STARD1, CYP11A1 and HSD3B. Front. Biosci 2012, 17, 824–846. [Google Scholar] [CrossRef]
  62. Hsu, H.J.; Lin, J.C.; Chung, B.C. Zebrafish cyp11a1 and hsd3b genes: Structure, expression and steroidogenic development during embryogenesis. Mol. Cell. Endocrinol. 2009, 312, 31–34. [Google Scholar] [CrossRef]
  63. Ye, W.; Tang, Q.; Wang, L.; Fang, C.; Xie, L.; He, Q.; Peng, K. Contribution of CYP19A1, CYP1A1, and CYP1A2 polymorphisms in coronary heart disease risk among the Chinese Han population. Funct. Integr. Genom. 2022, 22, 515–524. [Google Scholar] [CrossRef]
  64. Dickson, M.J.; Sheldon, I.M.; Bromfield, J.J. Lipopolysaccharide alters CEBPbeta signaling and reduces estradiol production in bovine granulosa cells. CABI Agric. Biosci. 2022, 3, 66. [Google Scholar] [CrossRef] [PubMed]
  65. Mohammed, Z.A.; Robinson, R.S.; Harris, R.; McLaughlin, Y.; Turnbull, K.E.; Mann, G.E.; Woad, K.J. Detrimental effects of uterine disease and lipopolysaccharide on luteal angiogenesis. J. Endocrinol. 2020, 245, 79–92. [Google Scholar] [CrossRef] [PubMed]
  66. Luttgenau, J.; Lingemann, B.; Wellnitz, O.; Hankele, A.K.; Schmicke, M.; Ulbrich, S.E.; Bruckmaier, R.M.; Bollwein, H. Repeated intrauterine infusions of lipopolysaccharide alter gene expression and lifespan of the bovine corpus luteum. J. Dairy. Sci. 2016, 99, 6639–6653. [Google Scholar] [CrossRef]
  67. Lin, F.; Zhang, S.; Zhu, X.; Lv, Z. Autophagy-related 7 proteindependent autophagy mediates resveratrol-caused upregulation of mitochondrial biogenesis and steroidogenesis in aged Leydig cell. Mol. Biol. Rep. 2023, 51, 28. [Google Scholar] [CrossRef] [PubMed]
  68. Zhang, N.; Shan, Y.; Lian, H.; Ma, X.; Zhang, W.; Liu, X.; Zhuang, L.; Liu, X.; Liu, Y.; Zheng, K. Resveratrol protects against high glucose-induced steroidogenesis and apoptosis in murine granulosa cells. Cell. Mol. Biol. 2023, 69, 218–222. [Google Scholar] [CrossRef]
  69. Pogrmic-Majkic, K.; Kosanin, G.; Samardzija Nenadov, D.; Fa, S.; Stanic, B.; Trninic Pjevic, A.; Andric, N. Rosiglitazone increases expression of steroidogenic acute regulatory protein and progesterone production through PPARgamma-EGFR-ERK1/2 in human cumulus granulosa cells. Reprod. Fertil. Dev. 2019, 31, 1647–1656. [Google Scholar] [CrossRef]
  70. Zhang, X.; Jiang, L.; Chen, H.; Wei, S.; Yao, K.; Sun, X.; Yang, G.; Jiang, L.; Zhang, C.; Wang, N.; et al. Resveratrol protected acrolein-induced ferroptosis and insulin secretion dysfunction via ER-stress- related PERK pathway in MIN6 cells. Toxicology 2022, 465, 153048. [Google Scholar] [CrossRef]
  71. Li, F.; Peng, J.; Feng, H.; Yang, Y.; Gao, J.; Liu, C.; Xu, J.; Zhao, Y.; Pan, S.; Wang, Y.; et al. KLF9 Aggravates Streptozotocin-Induced Diabetic Cardiomyopathy by Inhibiting PPARgamma/NRF2 Signalling. Cells 2022, 11, 3393. [Google Scholar] [CrossRef] [PubMed]
Antioxidants 14 01300 g001
Figure 1. Effect of different concentrations and times of LPS treatment on cell viability, antioxidative status, expressions of genes related to inflammation, and pyroptosis in goat GCs. (A–G) Cells were exposed to 0–16 μg/mL LPS for 12 h: (A) cell viability; (B) MDA content; (C) SOD activity; (D) T-AOC content; (E) ROS content detected by flow cytometer and quantitative analysis; (F) relative mRNA abundances of IL-1β, IL-6, and TNF-α; and (G) relative mRNA abundances of GSDMD, Caspase1, and NLRP3. (H) Cells were exposed to 4 μg/mL LPS for 0–24 h, and relative mRNA abundances of IL-1β, TNF-α, NLRP3, and GSDMD were detected. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group.
Figure 1. Effect of different concentrations and times of LPS treatment on cell viability, antioxidative status, expressions of genes related to inflammation, and pyroptosis in goat GCs. (A–G) Cells were exposed to 0–16 μg/mL LPS for 12 h: (A) cell viability; (B) MDA content; (C) SOD activity; (D) T-AOC content; (E) ROS content detected by flow cytometer and quantitative analysis; (F) relative mRNA abundances of IL-1β, IL-6, and TNF-α; and (G) relative mRNA abundances of GSDMD, Caspase1, and NLRP3. (H) Cells were exposed to 4 μg/mL LPS for 0–24 h, and relative mRNA abundances of IL-1β, TNF-α, NLRP3, and GSDMD were detected. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group.
Antioxidants 14 01300 g001
Antioxidants 14 01300 g002
Figure 2. Effect of different concentrations and times of RES treatment on cell viability, expressions of genes related to inflammation, and pyroptosis in goat GCs. (A) Cells were exposed to 0–10 μM RES for 12 h, and cell viability was detected; (B,C) cells were pretreated with 0.1, 1 μM Res for 12 h, followed by exposure to 4 μg/mL LPS for 12 h, and relative mRNA abundances of IL-1β, IL-6, and TNF-α (B) as well as NLRP3, Caspase1, and GSDMD (C) were detected; (D) cells were exposed to 1 μM RES for 0–24 h and cell viability was detected; (E,F) cells were pretreated with 1 μM Res for 6, 12, 18 h followed by exposure to 4 μg/mL LPS for 12 h, relative mRNA abundances of IL-1β, IL-6, and TNF-α (E) as well as NLRP3, Caspase1, and GSDMD (F) were detected. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group. # indicates p < 0.05 compared with LPS group.
Figure 2. Effect of different concentrations and times of RES treatment on cell viability, expressions of genes related to inflammation, and pyroptosis in goat GCs. (A) Cells were exposed to 0–10 μM RES for 12 h, and cell viability was detected; (B,C) cells were pretreated with 0.1, 1 μM Res for 12 h, followed by exposure to 4 μg/mL LPS for 12 h, and relative mRNA abundances of IL-1β, IL-6, and TNF-α (B) as well as NLRP3, Caspase1, and GSDMD (C) were detected; (D) cells were exposed to 1 μM RES for 0–24 h and cell viability was detected; (E,F) cells were pretreated with 1 μM Res for 6, 12, 18 h followed by exposure to 4 μg/mL LPS for 12 h, relative mRNA abundances of IL-1β, IL-6, and TNF-α (E) as well as NLRP3, Caspase1, and GSDMD (F) were detected. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group. # indicates p < 0.05 compared with LPS group.
Antioxidants 14 01300 g002
Antioxidants 14 01300 g003
Figure 3. Effect of different concentrations and times of GW9662 treatment on cell viability, PPARG expression, and genes related to inflammation and pyroptosis in goat GCs. (A) Cells were exposed to 0–20 μM GW9662 for 12 h and cell viability was detected; (B–D) cells were exposed to 0.1, 1, 5 μM GW9662 for 12 h, followed by 1 μM Res for 6 h and 4 μg/mL LPS for 12 h, relative mRNA abundances of PPARG (B), IL-1β, IL-6, and TNF-α (C), as well as NLRP3, Caspase1, and GSDMD (D) were detected; (E) cells were exposed to 1 μM GW9662 for 0–24 h and cell viability was detected; (F–H) cells were pretreated with to 1 μM GW9662 for 6, 12, 18 h, followed by 1 μM Res for 6 h and 4 μg/mL LPS for 12 h, relative mRNA abundances of PPARG (F), IL-1β, IL-6, and TNF-α (G), as well as NLRP3, Caspase1, and GSDMD (H) were detected. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group. # indicates p < 0.05 compared with LPS group. & indicates p < 0.05 compared with RES + LPS group.
Figure 3. Effect of different concentrations and times of GW9662 treatment on cell viability, PPARG expression, and genes related to inflammation and pyroptosis in goat GCs. (A) Cells were exposed to 0–20 μM GW9662 for 12 h and cell viability was detected; (B–D) cells were exposed to 0.1, 1, 5 μM GW9662 for 12 h, followed by 1 μM Res for 6 h and 4 μg/mL LPS for 12 h, relative mRNA abundances of PPARG (B), IL-1β, IL-6, and TNF-α (C), as well as NLRP3, Caspase1, and GSDMD (D) were detected; (E) cells were exposed to 1 μM GW9662 for 0–24 h and cell viability was detected; (F–H) cells were pretreated with to 1 μM GW9662 for 6, 12, 18 h, followed by 1 μM Res for 6 h and 4 μg/mL LPS for 12 h, relative mRNA abundances of PPARG (F), IL-1β, IL-6, and TNF-α (G), as well as NLRP3, Caspase1, and GSDMD (H) were detected. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group. # indicates p < 0.05 compared with LPS group. & indicates p < 0.05 compared with RES + LPS group.
Antioxidants 14 01300 g003
Antioxidants 14 01300 g004
Figure 4. Resveratrol alleviates LPS-induced oxidative stress by activating PPARG in goat GCs. Cells were treated with or without GW9662 (1 μM for 12 h), RES (1 μM for 6 h), or LPS (4 μg/mL for 12 h). (A) MDA content; (B) SOD activity; (C) T-AOC content; (D) relative mRNA abundances of SOD; (E) representative protein bands of SOD; (F) relative protein abundances of SOD; (G) representative immunofluorescence images of ROS, scale bar = 20 μm; (H) quantitative analysis of ROS immunofluorescence intensity. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group. # indicates p < 0.05 compared with LPS group. & indicates p < 0.05 compared with RES + LPS group.
Figure 4. Resveratrol alleviates LPS-induced oxidative stress by activating PPARG in goat GCs. Cells were treated with or without GW9662 (1 μM for 12 h), RES (1 μM for 6 h), or LPS (4 μg/mL for 12 h). (A) MDA content; (B) SOD activity; (C) T-AOC content; (D) relative mRNA abundances of SOD; (E) representative protein bands of SOD; (F) relative protein abundances of SOD; (G) representative immunofluorescence images of ROS, scale bar = 20 μm; (H) quantitative analysis of ROS immunofluorescence intensity. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group. # indicates p < 0.05 compared with LPS group. & indicates p < 0.05 compared with RES + LPS group.
Antioxidants 14 01300 g004
Antioxidants 14 01300 g005
Figure 5. Resveratrol alleviates LPS-induced inflammation and pyroptosis by activating PPARG in goat GCs. Cells were treated with or without GW9662 (1 μM for 12 h), RES (1 μM for 6 h), or LPS (4 μg/mL for 12 h). (A) Relative mRNA abundances of IL-1β; (B) representative protein bands of IL-1β; (C) relative protein abundances of IL-1β; (D) relative mRNA abundances of NLRP3, Caspase1, and GSDMD; (E) representative protein bands of GSDMD; (F) relative protein abundances of GSDMD; (G) representative fluorescence images of Caspase1 and quantitative analysis, scale bar = 20 μm; (H) representative fluorescence images of GSDMD and quantitative analysis, scale bar = 20 μm. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group. # indicates p < 0.05 compared with LPS group. & indicates p < 0.05 compared with RES + LPS group.
Figure 5. Resveratrol alleviates LPS-induced inflammation and pyroptosis by activating PPARG in goat GCs. Cells were treated with or without GW9662 (1 μM for 12 h), RES (1 μM for 6 h), or LPS (4 μg/mL for 12 h). (A) Relative mRNA abundances of IL-1β; (B) representative protein bands of IL-1β; (C) relative protein abundances of IL-1β; (D) relative mRNA abundances of NLRP3, Caspase1, and GSDMD; (E) representative protein bands of GSDMD; (F) relative protein abundances of GSDMD; (G) representative fluorescence images of Caspase1 and quantitative analysis, scale bar = 20 μm; (H) representative fluorescence images of GSDMD and quantitative analysis, scale bar = 20 μm. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group. # indicates p < 0.05 compared with LPS group. & indicates p < 0.05 compared with RES + LPS group.
Antioxidants 14 01300 g005
Antioxidants 14 01300 g006
Figure 6. Resveratrol alleviates the effect of LPS on hormone synthesis by activating PPARG in goat GCs. Cells were treated with or without GW9662 (1 μM for 12 h), RES (1 μM for 6 h) or LPS (4 μg/mL for 12 h). (A) E2 content; (B) relative mRNA abundances of CYP19A1 and HSD3B; (C) representative protein bands of HSD3B; (D) relative protein abundances of HSD3B. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group. # indicates p < 0.05 compared with LPS group. & indicates p < 0.05 compared with RES + LPS group.
Figure 6. Resveratrol alleviates the effect of LPS on hormone synthesis by activating PPARG in goat GCs. Cells were treated with or without GW9662 (1 μM for 12 h), RES (1 μM for 6 h) or LPS (4 μg/mL for 12 h). (A) E2 content; (B) relative mRNA abundances of CYP19A1 and HSD3B; (C) representative protein bands of HSD3B; (D) relative protein abundances of HSD3B. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group. # indicates p < 0.05 compared with LPS group. & indicates p < 0.05 compared with RES + LPS group.
Antioxidants 14 01300 g006
Antioxidants 14 01300 g007
Figure 7. Resveratrol alleviates the effect of LPS on GCs by activating PPARG/NRF2/HO-1 pathway. Cells were treated with or without GW9662 (1 μM for 12 h), RES (1 μM for 6 h), or LPS (4 μg/mL for 12 h). (A) Relative mRNA abundances of PPARG, NRF2, and HO-1; (B) representative protein bands of PPARG, NRF2, and HO-1; (C) relative protein abundances of PPARG, NRF2, and HO-1. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group. # indicates p < 0.05 compared with LPS group. & indicates p < 0.05 compared with RES + LPS group.
Figure 7. Resveratrol alleviates the effect of LPS on GCs by activating PPARG/NRF2/HO-1 pathway. Cells were treated with or without GW9662 (1 μM for 12 h), RES (1 μM for 6 h), or LPS (4 μg/mL for 12 h). (A) Relative mRNA abundances of PPARG, NRF2, and HO-1; (B) representative protein bands of PPARG, NRF2, and HO-1; (C) relative protein abundances of PPARG, NRF2, and HO-1. All data are presented as the mean ± SEM. * indicates p < 0.05 compared with CON group. # indicates p < 0.05 compared with LPS group. & indicates p < 0.05 compared with RES + LPS group.
Antioxidants 14 01300 g007
Table 1. Primer sequences used for RT-qPCR. All primers were amplified at a uniform annealing temperature of 60 °C.
Table 1. Primer sequences used for RT-qPCR. All primers were amplified at a uniform annealing temperature of 60 °C.
GeneGene IDPrimer Sequence (5′-3′)Product Length/bp
CATXM_005690077.3F: CATTACCAGATACTCCAAGGCGAAGG234
R: TGGCTATGGATAAAGGACGGAAACAG
Caspase-1NC_030822.1F: TATGCCTGGTCCTGTGACCT102
R: AGTCACTCTTTCAGCGGTGG
CYP19A1NM_001285747.1F: CAGCATGGTGTCCGAAGTTG133
R: GGGCCCAATTCCCAGAAAGT
GAPDHNM_001034034.1F: CGACTTCAACAGCGACACTCAC119
R: CCCTGTTGCTGTAGCCGAATTC
GSDMDNC_030821.1F: GTTATTGGCTCTGACTGGG120
R: GAAGCACGAACGTGGATG
HO-1NM_001285567.1F: CGGCAGCAAGGCACAAGACTC97
R: GAGGACCCATCGCAGGAGAGG
HSD3BNM_001285716.1F: AGACCAGAAGTTCGGGAGGAA292
R: TCTCCCTGTAGGAGTTGGGC
IL-1βXM-013967700.2F: CCACCTCCTCTCACAGGAAATG100
R: GATACCCAAGGCCACAGGAATC
IL-6NM-001285640.1F: TACCTGGACTTCCTCCAGAAC245
R: CGAATAGCTCTCAGGCTGAAC
NLRP3NC_030814.1F: CCGTCTGGGTGAGAGCGTGAA78
R: TCCTGTTGGCTCCTGTGTTCCT
NRF2NM_001314327.1F: GCCCAGTCTTCAATGCTCCTTCTC113
R: TTCCTCCCAAACTTGCTCAATGTCC
PPARGNM_001285658.1F: ATATCCCCGGCTTCGTGAAC210
R: CAGCAAACTCGAACTTGGGC
SODXM_018053428.1F: CGGCCTACGTGAACAACCTCAAC261
R: GGACACCAACAGATACAGCAGTCAG
TNF-aNM 001286442.1F: CCACGTTGTAGCCAACATCAG134
R: AGATGAGGTAAAGCCCGTCAG
Table 2. Details of antibodies for WB.
Table 2. Details of antibodies for WB.
AntibodiesCat No.SupplierDilutionHostAntigen Source
Primary antibody
Caspase-1A19792Abclonal1:1000RabbitHuman
GSDMDA17308Abclonal1:1000RabbitHuman
GAPDHA19056Abclonal1:1000RabbitHuman
HO-1A21452Abclonal1:1000RabbitHuman
IL-1βA16288Abclonal1:1000RabbitHuman
NRF2A11159Abclonal1:1000RabbitHuman
PPARGA0270Abclonal1:1000RabbitHuman
SOD24127-1-APProteintech1:1000RabbitHuman
TubulinAF7011Affinity1:2000RabbitHuman
Secondary antibody
HRP anti-rabbit IgGAS014Abclonal1:5000GoatHuman
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhao, J.; Zhou, X.; Cang, Z.; Liu, X.; Tariq, M.; Mao, D. Resveratrol Alleviates Effects of LPS on Estrogen Synthesis, Oxidative Stress, Inflammation, and Pyroptosis of Goat Granulosa Cells by Activating the PPARG/NRF2/HO-1 Signaling Pathway. Antioxidants 2025, 14, 1300. https://doi.org/10.3390/antiox14111300

AMA Style

Zhao J, Zhou X, Cang Z, Liu X, Tariq M, Mao D. Resveratrol Alleviates Effects of LPS on Estrogen Synthesis, Oxidative Stress, Inflammation, and Pyroptosis of Goat Granulosa Cells by Activating the PPARG/NRF2/HO-1 Signaling Pathway. Antioxidants. 2025; 14(11):1300. https://doi.org/10.3390/antiox14111300

Chicago/Turabian Style

Zhao, Jie, Xianyi Zhou, Zhen Cang, Xin Liu, Muhammad Tariq, and Dagan Mao. 2025. "Resveratrol Alleviates Effects of LPS on Estrogen Synthesis, Oxidative Stress, Inflammation, and Pyroptosis of Goat Granulosa Cells by Activating the PPARG/NRF2/HO-1 Signaling Pathway" Antioxidants 14, no. 11: 1300. https://doi.org/10.3390/antiox14111300

APA Style

Zhao, J., Zhou, X., Cang, Z., Liu, X., Tariq, M., & Mao, D. (2025). Resveratrol Alleviates Effects of LPS on Estrogen Synthesis, Oxidative Stress, Inflammation, and Pyroptosis of Goat Granulosa Cells by Activating the PPARG/NRF2/HO-1 Signaling Pathway. Antioxidants, 14(11), 1300. https://doi.org/10.3390/antiox14111300

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop